+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alkermes plc - logo

Alkermes is a leader in innovative medicines that address the needs of people living with debilitating diseases. Alkermes develops products that are designed to make a meaningful difference in the way patients manage their disease. Alkermes produces innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
From
Sustained Release Excipients - Global Strategic Business Report - Product Thumbnail Image

Sustained Release Excipients - Global Strategic Business Report

  • Report
  • November 2024
  • 94 Pages
  • Global
From
D Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

D Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Antidepressants Drugs Market 2024-2028 - Product Thumbnail Image

Antidepressants Drugs Market 2024-2028

  • Report
  • July 2024
  • 138 Pages
  • Global
From
From
From
From
From
From
Chronic Disease Markets for Sustained Released Injectables - Product Thumbnail Image

Chronic Disease Markets for Sustained Released Injectables

  • Report
  • December 2023
  • 217 Pages
  • Global
From
From
From
Extended Release Injectable Drugs - Product Thumbnail Image

Extended Release Injectable Drugs

  • Report
  • June 2023
  • 200 Pages
  • Global
From
From
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
Loading Indicator